Clinical Trial

Urine Albumin/Creatinine Ratio and Renal Function Differences in Phenotypes of Polycystic Ovary Syndrome.

Completed
View on ClinicalTrials.gov →
Summary
Since there are different metabolic effects in different phenotypes of polycystic ovary syndrome (PCOS); in this study; the investigators aimed to investigate whether there is a difference between glomerular filtration rate (eGFR) and urine albumin/creatinine ratio (ACR) levels in different PCOS phenotypes and compare healthy controls.
Trial Details
NCT Number NCT07441811
Lead Sponsor Uşak University
Conditions Polycystic Ovary Syndrome, Urine Albumin \(UAlb\), Urine Creatinine \(UCr\), Glomerular Filtration Rate
Enrollment 300 participants
Start Date 2022-04-01
Primary Completion 2022-09-01 (estimated)
Study Completion 2023-07-20 (estimated)
Updated on ClinicalTrials.gov 2026-03-02